Impact of diabetes on fibrinogen levels and its relationship with platelet reactivity and coronary artery disease: A single-centre study

被引:8
作者
Di Giovine, Gabriella [1 ]
Verdoia, Monica [1 ]
Barbieri, Lucia [1 ]
Schaffer, Alon [1 ]
Aimaretti, Gianluca [2 ]
Bellomo, Giorgio [2 ]
Marino, Paolo [1 ,2 ]
Suryapranata, Harry [3 ]
Sinigaglia, Fabiola [2 ]
De Luca, Giuseppe [1 ,2 ]
机构
[1] Eastern Piedmont Univ, Dept Cardiol, I-28100 Novara, Italy
[2] Eastern Piedmont Univ, Dept Translat Med, I-28100 Novara, Italy
[3] Radboud Univ Nijmegen Med Ctr, Dept Cardiol, Nijmegen, Netherlands
关键词
Fibrinogen; Diabetes mellitus; Coronary artery disease; ELEVATION-MYOCARDIAL-INFARCTION; PRIMARY ANGIOPLASTY; PLASMA-FIBRINOGEN; RISK-FACTORS; UNFRACTIONATED HEPARIN; STEMI PATIENTS; HEART-DISEASE; MORTALITY; ATHEROSCLEROSIS; EXTENT;
D O I
10.1016/j.diabres.2015.05.038
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Previous reports have suggested an association between elevated fibrinogen and CAD. Few studies have so far investigated the impact of diabetes on fibrinogen levels and its association with coronary artery disease (CAD) and platelet reactivity in diabetic patients that are therefore the aims of the current study. Methods: We measured fibrinogen in 3280 consecutive patients undergoing coronary angiography. Samples were collected at admission for fibrinogen levels assessment. Coronary disease was defined for at least 1 vessel stenosis > 50% as evaluated by QCA. Results: Diabetes was observed in 1201 out of 3280 patients. Diabetic patients were older with more hypercholesterolemia, hypertension, higher BMI, more renal failure, previous MI or coronary revascularization (p < 0.001, respectively) and smoking (p = 0.001). Diabetic patients were more often on ACE-inhibitors, ARBs, b-blockers, calcium-antagonists, diuretics, statins (p < 0.001, respectively), and ASA (p = 0.004). Diabetic patients displayed higher glycaemia and HbA1c (p < 0.001), higher creatinine and triglycerides (p < 0.001) but lower total and HDL cholesterol (p < 0.001) and haemoglobin (p < 0.001). Diabetic patients had higher fibrinogen levels (p = 0.003), however neither diabetes nor glucose homeostasis parameters resulted as independent predictors of hyperfibrinogenemia. Furthermore, among diabetic patients, higher fibrinogen levels did not affect platelet reactivity and were not associated with the prevalence of CAD (adjusted OR[95% CI] = 0.99 [0.82-1.19], p = 0.9). Similar results were found for severe CAD (adjusted OR[95% CI] = 0.94 [0.82-1.08], p = 0.40). Conclusions: Our study showed that diabetes and glycaemic control are not independent predictors of hyperfibrinogenemia. Among diabetic patients, elevated fibrinogen is not associated with platelet reactivity and the prevalence and extent of CAD. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:541 / 550
页数:10
相关论文
共 48 条
[1]  
Ang Lawrence, 2008, Ther Adv Cardiovasc Dis, V2, P485, DOI 10.1177/1753944708094736
[2]  
[Anonymous], 1992, LANCET, V339, P647
[3]   Inflammation Markers and Metabolic Characteristics of Subjects With 1-h Plasma Glucose Levels [J].
Bardini, Gianluca ;
Dicembrini, Ilaria ;
Cresci, Barbara ;
Rotella, Carlo Maria .
DIABETES CARE, 2010, 33 (02) :411-413
[4]   Diabetes and atherosclerosis - Epidemiology, pathophysiology, and management [J].
Beckman, JA ;
Creager, MA ;
Libby, P .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (19) :2570-2581
[5]   A Study of Plasma Fibrinogen Level in Type-2 Diabetes Mellitus and its Relation to Glycemic Control [J].
Bembde, Archana Sachin .
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2012, 28 (02) :105-108
[6]   Metformin Attenuates the Exacerbation of the Allergic Eosinophilic Inflammation in High Fat-Diet-Induced Obesity in Mice [J].
Calixto, Marina Ciarallo ;
Lintomen, Leticia ;
Andre, Diana Majoli ;
Leiria, Luiz Osorio ;
Ferreira, Danilo ;
Lellis-Santos, Camilo ;
Anhe, Gabriel Forato ;
Bordin, Silvana ;
Landgraf, Richardt Gama ;
Antunes, Edson .
PLOS ONE, 2013, 8 (10)
[7]   IS OXIDATIVE STRESS THE MISSING LINK BETWEEN INSULIN-RESISTANCE AND ATHEROSCLEROSIS [J].
CERIELLO, A ;
PIRISI, M .
DIABETOLOGIA, 1995, 38 (12) :1484-1485
[8]   ATHEROSCLEROSIS AS AN IMMUNE DISEASE [J].
CLERC, G .
MEDICAL HYPOTHESES, 1991, 36 (01) :24-26
[9]   Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality - An individual participant meta-analysis [J].
Danesh, J ;
Lewington, S ;
Thompson, SG ;
Lowe, GDO ;
Collins, R .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (14) :1799-1809
[10]   Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease - Meta-analyses of prospective studies [J].
Danesh, J ;
Collins, R ;
Appleby, P ;
Peto, R .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (18) :1477-1482